More Side Effects With Local Therapies for Prostate CancerJanuary 31, 2024Genitourinary CancerOncologyProstate Cancer
Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North AmericaJanuary 30, 2024Genitourinary CancerOncology
High-dose RT and long-term ADT improve survival in high-risk prostate cancerJanuary 26, 2024Genitourinary CancerProstate Cancer
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid AllegationsJanuary 25, 2024Genitourinary CancerBusiness of MedicineBreast CancerLung CancerMelanoma
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All MatterJanuary 24, 2024Genitourinary CancerOncologyProstate Cancer
Prostate Risks Similar for Testosterone Therapy and PlaceboJanuary 19, 2024Genitourinary CancerMixed TopicsOncologyProstate Cancer
Radiation Oncologists Fight for Payment Reform Amid CutsJanuary 19, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed Topics
CMS Okays Payment for Novel AI Prostate TestJanuary 16, 2024Genitourinary CancerOncologyBusiness of MedicineProstate Cancer
SUDs rates highest in head, neck, and gastric cancer survivorsJanuary 16, 2024Mixed TopicsAddiction MedicineMental HealthOncologyGenitourinary CancerWomen's Health
Side Effects of Local Treatment for Advanced Prostate Cancer May Linger for YearsJanuary 9, 2024Genitourinary CancerProstate Cancer
Optimal Follow-up After Fertility-Sparing Cervical Cancer SurgeryJanuary 9, 2024Genitourinary CancerOncologyWomen's Health
Active Surveillance for Low-Risk PCa: Sprint or Marathon?January 5, 2024Genitourinary CancerOncologyProstate Cancer
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUCOctober 25, 2023Genitourinary Cancer
